MitraClip Procedure Can Be Performed without General Anesthesia

Courtesy of Dr. Carlos Fava.

Avoiding general anesthesia in intervention procedures has the benefits of faster recovery and shorter hospitalization. This has been already analyzed in the context of TAVR, but not in MitraClip procedures.

Es posible realizar MitraClip sin anestesia general

The present study analyzed 232 patients receiving the MitraClip. 76 of these procedures were done under general anesthesia (32.7%) and 156 under deep sedation (67.3%).


Read also: The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup”.


Populations were similar in age, comorbidities, EuroScore, severity of mitral failure, left and right ventricular function, and renal function.

 

Both strategies saw safe MitraClip implantation, with no difference in number of implanted clips, or residual mitral failure (with low complications rate). Only 2 patients required conversion to general anesthesia. Total procedural time was lower with deep sedation (DS), driven mainly by preparation.

 

Intensive care was shorter with DS (2.6±4.4 vs. 1.5±1.4 p=0.003). However, hospital stay was similar.


Read also: New Study Confirms TAVR Durability at 5 Years”.


At 90 day follow up, both groups improved functional class and quality of life, saw reduced systolic pressure and BNP.

 

Conclusion

MitraClip implantation with DS is as safe and effective as with general anesthesia.

 

Commentary

Simplifying endovascular procedures with no quality compromise has always been beneficial.

 

Performing MitraClip procedures without general anesthesia reduced intensive care days, but with no difference in overall hospital stay. This might be because the researchers looked at patients between 2011 and 2015. After gaining experience and improving devices, this factor might improve as well. 

 

To know the kind of patients that will benefit from this strategy calls for further research.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: Deep Sedation Vs. Geneal Anesthesia in 232 patients undergoing Percutaneous Mitral Valve repair using the MitraClip® System.

Reference: Patrick Horn, et al Catheterization Cardiovascular Intervention 2017 Published online.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...